Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats.

Deguchi T, Takemoto M, Uehara N, Lindup WE, Suenaga A, Otagiri M.

J Pharmacol Exp Ther. 2005 Aug;314(2):932-8. Epub 2005 May 5.

PMID:
15879000
2.

Lopinavir protein binding in vivo through the 12-hour dosing interval.

Boffito M, Hoggard PG, Lindup WE, Bonora S, Sinicco A, Khoo SH, Di Perri G, Back DJ.

Ther Drug Monit. 2004 Feb;26(1):35-9.

PMID:
14749547
3.

Extraction of uraemic toxins with activated carbon restores the functional properties of albumin.

Sarnatskaya VV, Lindup WE, Ivanov AI, Yushko LA, Tjia J, Maslenny VN, Gurina NM, Nikolaev VG.

Nephron Physiol. 2003;95(1):p10-8.

PMID:
14520007
4.

Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat.

Tsutsumi Y, Deguchi T, Takano M, Takadate A, Lindup WE, Otagiri M.

J Pharmacol Exp Ther. 2002 Nov;303(2):880-7.

PMID:
12388676
5.

Albumin, bilirubin, and activated carbon: new edges of an old triangle.

Sarnatskaya VV, Lindup WE, Walther P, Maslenny VN, Yushko LA, Sidorenko AS, Nikolaev AV, Nikolaev VG.

Artif Cells Blood Substit Immobil Biotechnol. 2002 Mar;30(2):113-26.

PMID:
12027227
6.

Effect of protein-bound uraemic toxins on the thermodynamic characteristics of human albumin.

Sarnatskaya VV, Lindup WE, Niwa T, Ivanov AI, Yushko LA, Tjia J, Maslenny VN, Korneeva LN, Nikolaev VG.

Biochem Pharmacol. 2002 Apr 1;63(7):1287-96.

PMID:
11960605
7.

Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.

Holladay JW, Dewey MJ, Michniak BB, Wiltshire H, Halberg DL, Weigl P, Liang Z, Halifax K, Lindup WE, Back DJ.

Drug Metab Dispos. 2001 Mar;29(3):299-303.

PMID:
11181499
8.

Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?

Viale M, Vannozzi MO, Pastrone I, Mariggi├▓ MA, Zicca A, Cadoni A, Cafaggi S, Tolino G, Lunardi G, Civalleri D, Lindup WE, Esposito M.

J Pharmacol Exp Ther. 2000 Jun;293(3):829-36.

PMID:
10869382
9.

Tiopronin protects against the nephrotoxicity of cisplatin in the rat.

Zhang JG, Viale M, Esposito M, Lindup WE.

Hum Exp Toxicol. 1999 Dec;18(12):713-7.

PMID:
10627657
10.

Measurement of platinum in saliva of patients treated with cisplatin.

Holding JD, Lindup WE, Roberts NB, Salvatori P, Stell PM.

Ann Clin Biochem. 1999 Sep;36 ( Pt 5):655-9.

PMID:
10505218
11.

Cisplatin combined with tiopronin or sodium thiosulfate: cytotoxicity in vitro and antitumor activity in vivo.

Viale M, Zhang JG, Pastrone I, Mariggi├▓ MA, Esposito M, Lindup WE.

Anticancer Drugs. 1999 Apr;10(4):419-28.

PMID:
10378678
12.

Variability of mitomycin C adsorption by activated charcoal.

Shah IA, Lindup WE, McCulloch PG.

J Pharm Pharmacol. 1998 Mar;50(3):251-6.

PMID:
9600715
13.
14.

Tiopronin protects against the nephrotoxicity of cisplatin in rat renal cortical slices in vitro.

Zhang JG, Lindup WE.

Toxicol Appl Pharmacol. 1996 Dec;141(2):425-33.

PMID:
8975767
18.

Retention of an albumin-bound furan dicarboxylic acid in patients with chronic renal failure or after a kidney transplant.

Costigan MG, Yaqoob M, Lindup WE.

Nephrol Dial Transplant. 1996 May;11(5):803-7.

PMID:
8671898
19.

Role of calcium in cisplatin-induced cell toxicity in rat renal cortical slices.

Zhang JG, Lindup WE.

Toxicol In Vitro. 1996 Apr;10(2):205-9.

PMID:
20650198
20.
21.

Comparison of the toxicities of cisplatin and a new cisplatin-procaine complex to rat renal cortical slices.

Zhang JG, Esposito M, Cafaggi S, Lindup WE.

Hum Exp Toxicol. 1996 Jan;15(1):59-63.

PMID:
8845212
23.
24.
26.

Amelioration of cisplatin toxicity in rat renal cortical slices by dithiothreitol in vitro.

Zhang JG, Zhong LF, Zhang M, Ma XL, Xia YX, Lindup WE.

Hum Exp Toxicol. 1994 Feb;13(2):89-93.

PMID:
7908816
28.

Clinical pharmacokinetics.

Lindup WE.

Xenobiotica. 1993 Nov;23(11):1157-8. No abstract available.

PMID:
8310704
29.

Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices.

Zhang JG, Lindup WE.

Biochem Pharmacol. 1993 Jun 9;45(11):2215-22.

PMID:
8517862
31.

Cisplatin-albumin complex for treatment of cancer of the head and neck.

Vreeburg GC, Stell PM, Holding JD, Lindup WE.

J Laryngol Otol. 1992 Sep;106(9):832-3.

PMID:
1431527
32.

Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck.

Holding JD, Lindup WE, van Laer C, Vreeburg GC, Schilling V, Wilson JA, Stell PM.

Br J Clin Pharmacol. 1992 Jan;33(1):75-81.

33.

Failure of a 21-aminosteroid antioxidant to ameliorate cisplatin-induced nephrotoxicity.

Holding JD, Stell PM, Lindup WE.

Hum Exp Toxicol. 1991 Sep;10(5):323-6.

PMID:
1683544
34.
35.
36.
37.
38.

Excretion of the uraemic metabolite 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human urine.

McTigue JJ, Henderson SJ, Lindup WE.

Nephron. 1990;55(2):214-5. No abstract available.

39.
40.

Brain uptake of L-tryptophan and diazepam: the role of plasma protein binding.

Fenerty CA, Lindup WE.

J Neurochem. 1989 Aug;53(2):416-22.

PMID:
2746229
41.

Practolol: aspects of its metabolism and ocular binding in the hamster.

Rosenbaum SE, Lindup WE, Orton TC.

Xenobiotica. 1986 Jun;16(6):567-73.

PMID:
3751112
42.

Practolol and its metabolites: tissue localization and retention in the hamster.

Rosenbaum SE, Lindup WE, Orton TC.

J Pharmacol Exp Ther. 1985 Aug;234(2):485-90.

PMID:
4020682
43.

Scatchard plots with a positive slope: dependence upon ligand concentration.

Clegg LS, Lindup WE.

J Pharm Pharmacol. 1984 Nov;36(11):776-9.

PMID:
6150986
44.

Fluorescent materials in uremic fluids.

Lindup WE.

Clin Chem. 1983 Dec;29(12):2122-3. No abstract available.

PMID:
6640919
45.

Drug binding defect of uraemic plasma: unlikely involvement of carbamoylated albumin.

Clegg LS, Lindup WE.

Biochem Pharmacol. 1982 Sep 1;31(17):2791-4.

PMID:
7138574
47.

Clinical pharmacology: plasma protein binding of drugs.

Lindup WE, Orme MC.

Br Med J (Clin Res Ed). 1981 Jan 17;282(6259):212-4. No abstract available.

48.
49.
50.

The distribution and irreversible tissue binding of practolol and its metabolites in the hamster [proceedings].

Lindup WE, Longshaw S, Orton TC, Whittaker SE.

Br J Pharmacol. 1979 Jul;66(3):504P. No abstract available.

Supplemental Content

Loading ...
Support Center